Author: Li, Chang; Wang, Lin; Ren, Linzhu
Title: Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection Cord-id: tc892moq Document date: 2020_6_24
ID: tc892moq
Snippet: The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global pandemic. Up to now, numerous medicines have been applied or approved for the prevention and control of the virus infection. However, the efficiency of each medicine or combination is completely different or still unknown. In this review, we discuss the types, characteristics, antiviral mechanisms, and shortcomings of recommended candidate medicines for SARS-
Document: The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global pandemic. Up to now, numerous medicines have been applied or approved for the prevention and control of the virus infection. However, the efficiency of each medicine or combination is completely different or still unknown. In this review, we discuss the types, characteristics, antiviral mechanisms, and shortcomings of recommended candidate medicines for SARS-CoV-2 infection, as well as perspectives of the drugs for the disease treatment, which may provide a theoretical basis for drug screening and application.
Search related documents:
Co phrase search for related documents- activator signal transducer and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- active component and liver kidney: 1
- active component and lopinavir ritonavir: 1
- active component and low toxicity: 1
- active component and lung injury: 1, 2
- active form and additional nucleotide: 1
- active form and liver function: 1
- active form and liver kidney: 1
- active form and low toxicity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date